The role of LMNA in adipose: A novel mouse model of lipodystrophy based on the Dunnigan-type familial partial lipodystrophy mutation

Journal of Lipid Research

Volumn 50, Issue 6, 2009, Pages 1068-1079

  Wojtanik, Kari M ^a   Edgemon, Keith ^a,b   Viswanadha, Srikant ^a,c   Lindsey, Brigette ^a,b   Haluzik, Martin ^a,d   Chen, Weiping ^c   Poy, George ^a   Reitman, Marc ^b,e   Londos, Constantine ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b TTC Industrial Area ^*  (United States)

^c Maharashtra Industrial Development Corporation India   (India)

^d CHARLES UNIVERSITY   (Czech Republic)

^e MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Adipocyte differentiation; Insulin resistance; Lamin A; Lamin C; Laminopathies; Preadipocyte; Type 2 diabetes

Indexed keywords

LAMIN A; LAMININ;

ADIPOCYTE; ADIPOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL RENEWAL; CONTROLLED STUDY; FAMILIAL PARTIAL LIPODYSTROPHY; FATTY LIVER; GENE MUTATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; THERMOGENESIS; TRANSGENIC MOUSE;

ADIPOCYTES; ADIPOSE TISSUE; ADIPOSE TISSUE, BROWN; ANIMALS; BASE SEQUENCE; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; DNA PRIMERS; FATTY LIVER; HUMANS; INSULIN RESISTANCE; LAMIN TYPE A; LIPODYSTROPHY, FAMILIAL PARTIAL; LIPOLYSIS; MALE; MICE; MICE, TRANSGENIC; MUTATION; PHENOTYPE; THERMOGENESIS;

EID: 67650566605     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M800491-JLR200     Document Type: Article

References (56)

1. Agarwal, A. K., and A. Garg. 2006. Genetic basis of lipodystrophies and management of metabolic complications. Annu. Rev. Med. 57: 297-311.
2. Rajala, M. W., and P. E. Scherer. 2003. Minireview: The adipocyte- at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology. 144: 3765-3773.
3. Cao, H., and R. A. Hegele. 2000. Nuclear lamin A/C R482Qmutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum. Mol. Genet. 9: 109-112.
4. Jacob, K. N., and A. Garg. 2006. Laminopathies: multisystem dystrophy syndromes. Mol. Genet. Metab. 87: 289-302.
5. Garg, A., R. M. Peshock, and J. L. Fleckenstein. 1999. Adipose tissue distribution pattern in patients with familial partial lipodystrophy (Dunnigan variety). J. Clin. Endocrinol. Metab. 84: 170-174.
6. Hegele, R. A., H. Cao, C. M. Anderson, and I. M. Hramiak. 2000. Heterogeneity of nuclear lamin A mutations in Dunnigan-type familial partial lipodystrophy. J. Clin. Endocrinol. Metab. 85: 3431-3435.
7. Haque, W. A., F. Vuitch, and A. Garg. 2002. Post-mortem findings in familial partial lipodystrophy, Dunnigan variety. Diabet. Med. 19: 1022-1025.
8. Lin, F., and H. J. Worman. 1993. Structural organization of the human gene encoding nuclear lamin A and nuclear lamin C. J. Biol. Chem. 268: 16321-16326.
9. Corrigan, D. P., D. Kuszczak, A. E. Rusinol, D. P. Thewke, C. A. Hrycyna, S. Michaelis, and M. S. Sinensky. 2005. Prelamin A endoproteolytic processing in vitro by recombinant Zmpste24. Biochem. J. 387: 129-138.
10. Sasseville, A. M., and Y. Raymond. 1995. Lamin A precursor is localized to intranuclear foci. J. Cell Sci. 108: 273-285.
11. Aebi, U., J. Cohn, L. Buhle, and L. Gerace. 1986. The nuclear lamina is a meshwork of intermediate-type filaments. Nature. 323: 560-564.
12. Hutchison, C. J., and H. J. Worman. 2004. A-type lamins: guardians of the soma? Nat. Cell Biol. 6: 1062-1067.
13. Moir, R. D., T. P. Spann, and R. D. Goldman. 1995. The dynamic properties and possible functions of nuclear lamins. Int. Rev. Cytol. 162B: 141-182.
14. Hutchison, C. J. 2002. Lamins: building blocks or regulators of gene expression? Nat. Rev. Mol. Cell Biol. 3: 848-858.
15. Kennedy, B. K., D. A. Barbie, M. Classon, N. Dyson, and E. Harlow. 2000. Nuclear organization of DNA replication in primary mammalian cells. Genes Dev. 14: 2855-2868.
16. Ozaki, T., M. Saijo, K. Murakami, H. Enomoto, Y. Taya, and S. Sakiyama. 1994. Complex formation between lamin A and the retinoblastoma gene product: identification of the domain on lamin A required for its interaction. Oncogene. 9: 2649-2653.
17. Capanni, C., E. Mattioli, M. Columbaro, E. Lucarelli, V. K. Parnaik, G. Novelli, M. Wehnert, V. Cenni, N. M. Maraldi, S. Squarzoni, et al. 2005. Altered pre-lamin A processing is a common mechanism leading to lipodystrophy. Hum. Mol. Genet. 14: 1489-1502.
18. Lloyd, D. J., R. C. Trembath, and S. Shackleton. 2002. A novel interaction between lamin A and SREBP1: implications for partial lipodystrophy and other laminopathies. Hum. Mol. Genet. 11: 769-777.
19. Genschel, J., and H. H. Schmidt. 2000. Mutations in the LMNA gene encoding lamin A/C. Hum. Mutat. 16: 451-459.
20. Mounkes, L., S. Kozlov, B. Burke, and C. L. Stewart. 2003. The laminopathies: nuclear structure meets disease. Curr. Opin. Genet. Dev. 13: 223-230.
21. Mattout, A., T. Dechat, S. A. Adam, R. D. Goldman, and Y. Gruenbaum. 2006. Nuclear lamins, diseases and aging. Curr. Opin. Cell Biol. 18: 335-341.
22. Moitra, J., M. M. Mason, M. Olive, D. Krylov, O. Gavrilova, B. Marcus-Samuels, L. Feigenbaum, E. Lee, T. Aoyama, M. Eckhaus, et al. 1998. Life without white fat: a transgenic mouse. Genes Dev. 12: 3168-3181.
23. Speckman, R. A., A. Garg, F. Du, L. Bennett, R. Veile, E. Arioglu, S. I. Taylor, M. Lovett, and A. M. Bowcock. 2000. Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C. Am. J. Hum. Genet. 66: 1192-1198.
24. Chen, M., M. Haluzik, N. J. Wolf, J. Lorenzo, K. R. Dietz, M. L. Reitman, and L. S. Weinstein. 2004. Increased insulin sensitivity in paternal Gnas knockout mice is associated with increased lipid clearance. Endocrinology. 145: 4094-4102.
25. Rodbell, M. 1964. Metabolism of isolated fat cells. I. Effects of hormones on glucosemetabolism and lipolysis. J. Biol. Chem. 239: 375-380.
26. Honnor, R. C., G. S. Dhillon, and C. Londos. 1985. cAMP-dependent protein kinase and lipolysis in rat adipocytes. II. Definition of steadystate relationship with lipolytic and antilipolytic modulators. J. Biol. Chem. 260: 15130-15138.
27. Honnor, R. C., G. S. Dhillon, and C. Londos. 1985. cAMP-dependent protein kinase and lipolysis in rat adipocytes. I. Cell preparation, manipulation, and predictability in behavior. J. Biol. Chem. 260: 15122-15129.
28. Bradley, D. C., and H. R. Kaslow. 1989. Radiometric assays for glycerol, glucose, and glycogen. Anal. Biochem. 180: 11-16.
29. Brasaemle, D. L., D. M. Levin, D. C. Adler-Wailes, and C. Londos. 2000. The lipolytic stimulation of 3T3-L1 adipocytes promotes the translocation of hormone-sensitive lipase to the surfaces of lipid storage droplets. Biochim. Biophys. Acta. 1483: 251-262.
30. Kang, S., L. Bajnok, K. A. Longo, R. K. Petersen, J. B. Hansen, K. Kristiansen, and O. A. MacDougald. 2005. Effects of Wnt signaling on brown adipocyte differentiation and metabolism mediated by PGC-1 {alpha}. Mol. Cell. Biol. 25: 1272-1282.
31. Lomax, M. A., F. Sadiq, G. Karamanlidis, A. Karamitri, P. Trayhurn, and D. G. Hazlerigg. 2007. Ontogenic loss of brown adipose tissue sensitivity to {beta}-adrenergic stimulation in the ovine. Endocrinology. 148: 461-468.
32. Yang, X., S. Enerback, and U. Smith. 2003. Reduced expression of FOXC2 and brown adipogenic genes in human subjects with insulin resistance. Obes. Res. 11: 1182-1191.
33. Vantyghem, M. C., P. Pigny, C. A. Maurage, N. Rouaix-Emery, T. Stojkovic, J. M. Cuisset, A. Millaire, O. Lascols, P. Vermersch, J. L. Wemeau, et al. 2004. Patients with familial partial lipodystrophy of the Dunnigan type due to a LMNA R482W mutation show muscular and cardiac abnormalities. J. Clin. Endocrinol. Metab. 89: 5337-5346.
34. Boguslavsky, R. L., C. L. Stewart, and H. J. Worman. 2006. Nuclear lamin A inhibits adipocyte differentiation: implications for Dunnigantype familial partial lipodystrophy. Hum. Mol. Genet. 15: 653-663.
35. Araujo-Vilar, D., L. Loidi, F. Dominguez, and J. Cabezas-Cerrato. 2003. Phenotypic gender differences in subjects with familial partial lipodystrophy (Dunnigan variety) due to a nuclear lamin A/C R482W mutation. Horm. Metab. Res. 35: 29-35.
36. Haque, W. A., E. A. Oral, K. Dietz, A. M. Bowcock, A. K. Agarwal, and A. Garg. 2003. Risk factors for diabetes in familial partial lipodystrophy, Dunnigan variety. Diabetes Care. 26: 1350-1355.
37. Ludtke, A., J. Genschel, G. Brabant, J. Bauditz, M. Taupitz, M. Koch, W. Wermke, H. J. Worman, and H. H. Schmidt. 2005. Hepatic steatosis in Dunnigan-type familial partial lipodystrophy. Am. J. Gastroenterol. 100: 2218-2224.
38. Cannon, B., and J. Nedergaard. 2004. Brown adipose tissue: function and physiological significance. Physiol. Rev. 84: 277-359.
39. Nedergaard, J., T. Bengtsson, and B. Cannon. 2007. Unexpected evidence for active brown adipose in adult humans. Am. J. Physiol. Endocrinol. Metab. 293: E444-E452.
40. Johansen, K., M. H. Rasmussen, L. L. Kjems, and A. Astrup. 1995. An unusual type of familial lipodystrophy. J. Clin. Endocrinol. Metab. 80: 3442-3446.
41. Ross, S. R., R. A. Graves, A. Greenstein, K. A. Platt, H. L. Shyu, B. Mellovitz, and B. M. Spiegelman. 1990. A fat-specific enhancer is the primary determinant of gene expression for adipocyte P2 in vivo. Proc. Natl. Acad. Sci. USA. 87: 9590-9594.
42. Rosen, E. D., and B. M. Spiegelman. 2000. Molecular regulation of adipogenesis. Annu. Rev. Cell Dev. Biol. 16: 145-171.
43. Lelliott, C. J., L. Logie, C. P. Sewter, D. Berger, P. Jani, F. Blows, S. O'Rahilly, and A. Vidal-Puig. 2002. Lamin expression in human adipose cells in relation to anatomical site and differentiation state. J. Clin. Endocrinol. Metab. 87: 728-734.
44. Adams, M., C. T. Montague, J. B. Prins, J. C. Holder, S. A. Smith, L. Sanders, J. E. Digby, C. P. Sewter, M. A. Lazar, V. K. Chatterjee, et al. 1997. Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation. J. Clin. Invest. 100: 3149-3153.
45. Yanase, T., T. Yashiro, K. Takitani, S. Kato, S. Taniguchi, R. Takayanagi, and H. Nawata. 1997. Differential expression of PPAR gamma1 and gamma2 isoforms in human adipose tissue. Biochem. Biophys. Res. Commun. 233: 320-324.
46. Tchkonia, T., N. Giorgadze, T. Pirtskhalava, Y. Tchoukalova, I. Karagiannides, R. A. Forse, M. DePonte, M. Stevenson, W. Guo, J. Han, et al. 2002. Fat depot origin affects adipogenesis in primary cultured and cloned human preadipocytes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282: R1286-R1296.
47. Garg, A. 2000. Gender differences in the prevalence of metabolic complications in familial partial lipodystrophy (Dunnigan variety). J. Clin. Endocrinol. Metab. 85: 1776-1782.
48. Haluzik, M., C. Colombo, O. Gavrilova, S. Chua, N. Wolf, M. Chen, B. Stannard, K. R. Dietz, D. Le Roith, and M. L. Reitman. 2004. Genetic background (C57BL/6J versus FVB/N) strongly influences the severity of diabetes and insulin resistance in ob/ob mice. Endocrinology. 145: 3258-3264.
49. Ricci, M., M. Pellizzon, E. Ulman, J. Denier, and E. Arlund. 2005. Diet-induced obesity (DIO) is affected by level of dietary fat and gender in C57BL/6 mice. NAASO Annual Scientific Meeting, Vancouver, BC. 2005.
50. Burant, C. F., S. Sreenan, K. Hirano, T. A. Tai, J. Lohmiller, J. Lukens, N. O. Davidson, S. Ross, and R. A. Graves. 1997. Troglitazone action is independent of adipose tissue. J. Clin. Invest. 100: 2900-2908.
51. Shimomura, I., R. E. Hammer, S. Ikemoto, M. S. Brown, and J. L. Goldstein. 1999. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature. 401: 73-76.
52. Park, J. Y., O. Gavrilova, and P. Gorden. 2006. The clinical utility of leptin therapy in metabolic dysfunction. Minerva Endocrinol. 31: 125-131.
53. Pajvani, U. B., M. E. Trujillo, T. P. Combs, P. Iyengar, L. Jelicks, K. A. Roth, R. N. Kitsis, and P. E. Scherer. 2005. Fat apoptosis through targeted activation of caspase 8: a new mouse model of inducible and reversible lipoatrophy. Nat. Med. 11: 797-803.
54. Shum, B. O., C. R. Mackay, C. Z. Gorgun, M. J. Frost, R. K. Kumar, G. S. Hotamisligil, and M. S. Rolph. 2006. The adipocyte fatty acid-binding protein aP2 is required in allergic airway inflammation. J. Clin. Invest. 116: 2183-2192.
55. Weisberg, S. P., D. McCann, M. Desai, M. Rosenbaum, R. L. Leibel, and A. W. Ferrante, Jr. 2003. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112: 1796-1808.
56. Xu, H., G. T. Barnes, Q. Yang, G. Tan, D. Yang, C. J. Chou, J. Sole, A. Nichols, J. S. Ross, L. A. Tartaglia, et al. 2003. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112: 1821-1830.